ERBB2 and non-small cell lung carcinoma: Thus, we aimed to characterize the clinical and histopathological features, treatment patterns, and clinical outcomes of EGFR and HER2 ex20ins patients in this retrospective multi-centre real-world analysis of a Canadian NSCLC population.